Citation 83776

MATSUDA,H: KAGEURA,T: TOGUCHIDA,I: MURAKAMI,T: KISHI,A: YOSHIKAWA,M:. (1999). EFFECTS OF SESQUITERPENES AND TRITERPENES FROM THE RHIZOME OF ALISMA OREENTALE ON NITRIC OXIDE PRODUCTION IN LIPOPOLYSACCHARIDE-ACTIVATED MACROPHAGES: ABSOLUTE STEREOSTRUCTURES OF ALISMAKETONES-B 23-ACETATE AND -C 23-ACETATE.. 9(21)

Citation Details

Title	EFFECTS OF SESQUITERPENES AND TRITERPENES FROM THE RHIZOME OF ALISMA OREENTALE ON NITRIC OXIDE PRODUCTION IN LIPOPOLYSACCHARIDE-ACTIVATED MACROPHAGES: ABSOLUTE STEREOSTRUCTURES OF ALISMAKETONES-B 23-ACETATE AND -C 23-ACETATE.
Authors	MATSUDA,H: KAGEURA,T: TOGUCHIDA,I: MURAKAMI,T: KISHI,A: YOSHIKAWA,M:
Year	1999
Volume	9
Issue	21

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Alisma orientale (ALISMATACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	ALISMOL	None
2	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMOL	INACTIVE
3	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMOL	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OF	ALISMOXIDE	None
5	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMOXIDE	INACTIVE
6	Not specified	ISOLATION AND IDENTIFICATION OF	ORIENTALOL A	None
7	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ORIENTALOL A	INACTIVE
8	Not specified	ISOLATION AND IDENTIFICATION OF	ORIENTALOL C	None
9	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ORIENTALOL C	INACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OF	GERMACRENE D	None
11	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMACRENE D	INACTIVE
12	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL A	None
13	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL A	INACTIVE
14	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL A MONOACETATE	None
15	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL A MONOACETATE	INACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL B	None
17	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL B	INACTIVE
18	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL B MONOACETATE	None
19	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL B MONOACETATE	INACTIVE
20	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL C MONOACETATE	None
21	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL C MONOACETATE	INACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL E	None
23	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL E	INACTIVE
24	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL E 23-ACETATE	None
25	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL E 23-ACETATE	INACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL F	None
27	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL F	INACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL G	None
29	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL G	INACTIVE
30	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL H	None
31	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL H	INACTIVE
32	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL I	None
33	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL I	INACTIVE
34	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL K 23-ACETATE	None
35	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL K 23-ACETATE	INACTIVE
36	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL L 23-ACETATE	None
37	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL L 23-ACETATE	WEAK ACTIVITY
38	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL M 23-ACETATE	None
39	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL M 23-ACETATE	WEAK ACTIVITY
40	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL N 23-ACETATE	None
41	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL N 23-ACETATE	INACTIVE
42	Not specified	ISOLATION AND IDENTIFICATION OF	ALISOL B,11-DEOXY:	None
43	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISOL B,11-DEOXY:	INACTIVE
44	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ALISMAKETONE B 23-ACETATE	None
45	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMAKETONE B 23-ACETATE	INACTIVE
46	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ALISMAKETONE C 23-ACETATE	None
47	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMAKETONE C 23-ACETATE	INACTIVE
48	Not specified	ISOLATION AND IDENTIFICATION OF	ALISMALACTONE 23-ACETATE	None
49	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMALACTONE 23-ACETATE	INACTIVE
50	Not specified	ISOLATION AND IDENTIFICATION OF	ALISMALACTONE,3-METHYL: 23-ACETATE	None
51	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMALACTONE,3-METHYL: 23-ACETATE	WEAK ACTIVITY

Citation 83776

Citation Details

Summary

Organisms and Their Experiments (1)

Alisma orientale (ALISMATACEAE)

Show SPARQL Queries (1)

Query 1